A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice - PubMed (original) (raw)
A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice
I A Khan et al. Proc Natl Acad Sci U S A. 1997.
Abstract
Production of nitric oxide by macrophages is believed to be an important microbicidal mechanism for a variety of intracellular pathogens, including Toxoplasma gondii. Mice with a targeted disruption of the inducible nitric oxide synthase gene (iNOS) were infected orally with T. gondii tissue cysts. Time to death was prolonged compared with parental controls. Histologic analysis of tissue from infected mice showed scattered small foci of inflammation with parasites in various tissues of iNOS-/- mice, whereas tissue from the parental C57BL/6 mice had more extensive tissue inflammation with few visible parasites. In particular, extensive ulceration and necrosis of distal small intestine and fatty degeneration of the liver was seen in the parental mice at day 7 postinfection, as compared with the iNOS-/- mice where these tissues appeared normal. Serum interferon gamma and tumor necrosis factor alpha levels postinfection were equally elevated in both mouse strains. Treatment of the parental mice with a NO synthase inhibitor, aminoguanidine, prevented early death in these mice as well as the hepatic degeneration and small bowel necrosis seen in acutely infected control parentals. These findings indicate that NO production during acute infection with T. gondii can kill intracellular parasites but can be detrimental, even lethal, to the host.
Figures
Figure 1
Survival of iNOS−/− mice from oral T. gondii challenge. iNOS−/− and parental mice (n = 8/group) were orally infected with different number of cysts containing bradyzoites of T. gondii and mortality monitored. This study was performed three times with similar findings. Data presented are representative of one experiment.
Figure 2
Cytokine mRNA expression after T. gondii infection in iNOS−/− and parental mice. Mice were uninfected (−) or infected orally (+) with 50 cysts and on day 7 p.i. splenocytes from three mice were harvested and pooled, and mRNA expression for IFNγ and IL-10 was assayed by reverse transcriptase–PCR. The differences in the transcriptional level for both the genes are expressed relative to those mice treated with saline (level designated as 1). The cDNA concentration examined at each point was standardized to the hypoxanthine phosphoribosyltransferase mRNA level (not shown).
Figure 3
Photomicrographs of mouse tissues 7 days p.i. with T. gondii, processed as specified in Materials and Methods. Bars equal 30 μM. (A) Liver of C57BL/6 parental mouse showing an inflammatory nodule surrounded by hepatocytes with marked fatty degeneration. (B) Liver of iNOS−/− mouse showing acute inflammatory nodule among largely preserved hepatocytes. (C) Liver of sham-treated C57BL/6 parental mouse with changes similar to the untreated parental mouse. (D) Liver of aminoguanidine-treated parental mouse with inflammation but preservation of hepatocyte morphology. (E) Brain of parental mouse with acute inflammation and necrosis. (F) Brain of iNOS−/− mouse, with acute inflammation. Arrow indicates T. gondii tachyzoites.
Figure 4
Photomicrographs of mouse distal ileum 7 days p.i. with T. gondii. (A and B) Parental C57BL/6 mouse showing acute necrosis of small bowel villi with acute inflammatory infiltration and ulceration. (A) Bar equals 100 μM. (B) Bar equals 200 μM. (C) Parental mouse treated with aminoguanidine showing preservation of small bowel epithelium. Bar equals 100 μM. (D) iNOS−/− mouse with normal small bowel epithelium. Bar equals 75 μM.
Figure 5
Levels of parasite DNA in the organs of iNOS−/− and parental mice infected with T. gondii. Mice (n = 3/group) were infected orally with 50 cysts of T. gondii. DNA was prepared from the brain and liver of mice 7 days p.i. A slot blot analysis was probed with _T. gondii_-specific B1 sequence. The scanned auto radiogram was quantitated by NIH Image that used DNA from a known number of extracellular tachyzoites as control. Bars represent the average number of parasites detected in each tissue.
Figure 6
Levels of iNOS message in the intestine and liver of C57BL/6 mice infected with T. gondii. Mice were infected orally with cysts. On day 0, 4, and 7 p.i. the liver and distal ileum were isolated and stored at −70°C. The pooled tissues from three mice at each time point were homogenized, and mRNA expression for iNOS was assayed by reverse transcription–PCR. The transcriptional level is expressed relative to uninfected mice (designated as 1). The cDNA concentration examined at each point was standardized to the hypoxanthine phosphoribosyltransferase mRNA level (not shown).
Figure 7
Effect of aminoguanidine treatment on the susceptibility of mice infected with T. gondii. Parental mice (n = 6/group) were infected with 50 cysts and treated daily with 100 mg/kg body weight of aminoguanidine. Control mice were infected and administered saline. The experiment was performed twice with similar findings. The data presented is representative of one experiment.
Similar articles
- The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S, Takemura M, Hamakawa H, Seishima M, Saito K. Fujigaki S, et al. Adv Exp Med Biol. 2003;527:97-103. doi: 10.1007/978-1-4615-0135-0_11. Adv Exp Med Biol. 2003. PMID: 15206721 - Heat shock protein 70 is a potential virulence factor in murine toxoplasma infection via immunomodulation of host NF-kappa B and nitric oxide.
Dobbin CA, Smith NC, Johnson AM. Dobbin CA, et al. J Immunol. 2002 Jul 15;169(2):958-65. doi: 10.4049/jimmunol.169.2.958. J Immunol. 2002. PMID: 12097402 - Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.
Kang KM, Lee GS, Lee JH, Choi IW, Shin DW, Lee YH. Kang KM, et al. Korean J Parasitol. 2004 Dec;42(4):175-83. doi: 10.3347/kjp.2004.42.4.175. Korean J Parasitol. 2004. PMID: 15591835 Free PMC article. - Mechanisms of innate resistance to Toxoplasma gondii infection.
Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, Sher A. Alexander J, et al. Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1355-9. doi: 10.1098/rstb.1997.0120. Philos Trans R Soc Lond B Biol Sci. 1997. PMID: 9355127 Free PMC article. Review.
Cited by
- Zingiber officinale Ameliorates Acute Toxoplasmosis-Induced Pathology in Mice.
El-Kady AM, Elshazly H, Alsulami MN, Albohiri HH, Alshehri EA, Alfaifi MS, Mohamed K, Wakid MH, Gattan HS, Altwaim SA, Al-Megrin WAI, Almalki GH, Abdel-Rahman IAM, Elshabrawy HA, Younis S. El-Kady AM, et al. Acta Parasitol. 2024 Sep 3. doi: 10.1007/s11686-024-00884-1. Online ahead of print. Acta Parasitol. 2024. PMID: 39225734 - Effective factors in the pathogenesis of Toxoplasma gondii.
Nayeri T, Sarvi S, Daryani A. Nayeri T, et al. Heliyon. 2024 May 19;10(10):e31558. doi: 10.1016/j.heliyon.2024.e31558. eCollection 2024 May 30. Heliyon. 2024. PMID: 38818168 Free PMC article. Review. - iNOS is necessary for GBP-mediated T. gondii clearance in murine macrophages via vacuole nitration and intravacuolar network collapse.
Zhao XY, Lempke SL, Urbán Arroyo JC, Brown IG, Yin B, Magaj MM, Holness NK, Smiley J, Redemann S, Ewald SE. Zhao XY, et al. Nat Commun. 2024 Mar 27;15(1):2698. doi: 10.1038/s41467-024-46790-y. Nat Commun. 2024. PMID: 38538595 Free PMC article. - IFNs in host defence and parasite immune evasion during Toxoplasma gondii infections.
Lüder CGK. Lüder CGK. Front Immunol. 2024 Feb 7;15:1356216. doi: 10.3389/fimmu.2024.1356216. eCollection 2024. Front Immunol. 2024. PMID: 38384452 Free PMC article. Review. - A Combination of Four Nuclear Targeted Effectors Protects Toxoplasma Against Interferon Gamma Driven Human Host Cell Death During Acute Infection.
Henry B, Sibley LD, Rosenberg A. Henry B, et al. bioRxiv [Preprint]. 2023 Dec 25:2023.12.24.573224. doi: 10.1101/2023.12.24.573224. bioRxiv. 2023. PMID: 38234811 Free PMC article. Updated. Preprint.
References
- Gazzinelli R T, Wysocka M, Hayashi S, Denkers E Y, Hieny S, Caspar P, Trinchieri G, Sher A. J Immunol. 1994;153:2533–2543. - PubMed
- Kasper L H, Matsuura T, Khan I A. J Immunol. 1995;155:4798–4804. - PubMed
- Khan I A, Kasper L H. J Immunol. 1996;157:2103–2108. - PubMed
- Suzuki Y, Orellana R, Schreiber R D, Remington J S. Science. 1988;240:516–518. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources